Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin Gibson

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Chest|June 3, 2024
Understanding the Added Value of High-Resolution CT Beyond Chest X-Ray in Determining Extent of Physiologic ImpairmentBryan S Benn, William L Lippitt, Isabel Cortopassi, et al.
Annals of the American Thoracic Society|August 11, 2020
The Pulmonary Fibrosis Foundation Patient Registry. Rationale, Design, and MethodsBonnie R Wang, Rex Edwards, Elizabeth A Freiheit, et al.
Seminars in Arthritis and Rheumatism|March 28, 2026
Prognostic significance of 1-year pulmonary function changes in inflammatory myopathy-related interstitial lung diseaseShiri Keret, Silvia Martinez Laverde, Raisa Lomanto Silva, et al.
Global Change Biology|September 4, 2016
The unseen invaders: introduced earthworms as drivers of change in plant communities in North American forests (a meta-analysis)Dylan Craven, Madhav P Thakur, Erin K Cameron, et al.
American Journal of Respiratory and Critical Care Medicine|August 8, 2017
Extracellular Mitochondrial DNA Is Generated by Fibroblasts and Predicts Death in Idiopathic Pulmonary FibrosisChangwan Ryu, Huanxing Sun, Mridu Gulati, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2024
Toll-Like-Receptor 5 protects against pulmonary fibrosis by reducing lung dysbiosisYosuke Sakamachi, Emma Wiley, Alma Solis, et al.
Science Translational Medicine|June 3, 2026
Toll-like receptor 5 protects against murine lung fibrosis through reduced dysbiosis, and <i>TLR5</i> deficiency is associated with human IPFYosuke Sakamachi, Emma Wiley, Carol S Trempus, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Chest|June 3, 2024
Understanding the Added Value of High-Resolution CT Beyond Chest X-Ray in Determining Extent of Physiologic ImpairmentBryan S Benn, William L Lippitt, Isabel Cortopassi, et al.
Annals of the American Thoracic Society|August 11, 2020
The Pulmonary Fibrosis Foundation Patient Registry. Rationale, Design, and MethodsBonnie R Wang, Rex Edwards, Elizabeth A Freiheit, et al.
Seminars in Arthritis and Rheumatism|March 28, 2026
Prognostic significance of 1-year pulmonary function changes in inflammatory myopathy-related interstitial lung diseaseShiri Keret, Silvia Martinez Laverde, Raisa Lomanto Silva, et al.
Global Change Biology|September 4, 2016
The unseen invaders: introduced earthworms as drivers of change in plant communities in North American forests (a meta-analysis)Dylan Craven, Madhav P Thakur, Erin K Cameron, et al.
American Journal of Respiratory and Critical Care Medicine|August 8, 2017
Extracellular Mitochondrial DNA Is Generated by Fibroblasts and Predicts Death in Idiopathic Pulmonary FibrosisChangwan Ryu, Huanxing Sun, Mridu Gulati, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2024
Toll-Like-Receptor 5 protects against pulmonary fibrosis by reducing lung dysbiosisYosuke Sakamachi, Emma Wiley, Alma Solis, et al.
Science Translational Medicine|June 3, 2026
Toll-like receptor 5 protects against murine lung fibrosis through reduced dysbiosis, and <i>TLR5</i> deficiency is associated with human IPFYosuke Sakamachi, Emma Wiley, Carol S Trempus, et al.
Pageof 3